Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity
1 other identifier
observational
70
1 country
1
Brief Summary
Observe Timing to complete healing of wounds \& Limb salvage in both cohorts those who are undergoing Debridement only and those who are undergoing Debridement plus PTA
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2022
CompletedFirst Posted
Study publicly available on registry
September 23, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedNovember 26, 2024
November 1, 2024
1.8 years
September 19, 2022
November 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection With Borderline Vascularity
1. Observe the timing to complete wound healing in both cohorts those with Debridement only \& those with Debridment plus PTA 2. Observe the Rate of limb salvage in both groups
1 YEAR
Secondary Outcomes (1)
Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection With Borderline Vascularity
1 YEAR
Study Arms (2)
ANGIOPLASTY GROUP
All patients undergoing PTA are going to be classified according to GLASS staging system
DEBRIDEMENT GROUP
The most commonly used technique for diabetic foot ulcers is sharp or surgical debridement using a scalpel, tissue forceps or similar instruments. It should be sufficiently extensive to remove all infected and necrotic tissue;
Interventions
SURGICAL DEBRIDEMNT
Eligibility Criteria
On the other hand we can consider patients as Borderline ischemia/ Boarderline Vascularity with (Rutherford Grade "I" Categories "2\&3) when they have a borderline ankle systolic pressure
You may qualify if:
- Patients will be included in this study are those suffering from DFUs; and Borderline Ischemia (BLI) / Borderline Vacularity with (Rutherford Grade "I" Categories "2\&3") when they have a borderline ankle systolic pressure
You may not qualify if:
- All patients with (CLI) and DFUs as they are indicated for urgent re-vascularization.
- Severely infected/ gangrenous wounds requiring amputation hindering possible limb salvage.
- Lesions lying within or adjacent to an aneurysm; Non diabetic cases with foot ulcers; Arteritic lesions;(Vasculitic Patients). Patients had prior major amputation, bypass surgery, and endarterectomy on any vessel of the ipsilateral (target) extremity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of vascular surgery - Assiut University Hospital
Asyut, Asyut Governorate, 71515, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 19, 2022
First Posted
September 23, 2022
Study Start
January 1, 2023
Primary Completion
November 1, 2024
Study Completion
September 1, 2025
Last Updated
November 26, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share